Publication | Closed Access
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
230
Citations
17
References
2018
Year
CLDN18.2-specific CAR T cells could be a promising treatment strategy for gastric cancer and potentially other CLDN18.2-positive tumors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1